Lakewood-Amedex Biotherapeutics, Inc.
LABT
$2.24
-$0.09-3.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.77M | -923.30K | -744.90K | -1.91M | -655.90K |
| Total Depreciation and Amortization | 30.70K | 30.50K | 30.30K | 30.10K | 29.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.50M | 46.20K | 46.70K | 1.20M | 48.90K |
| Change in Net Operating Assets | -858.00K | 496.90K | 245.90K | 62.90K | 68.60K |
| Cash from Operations | -2.10M | -349.70K | -422.00K | -610.00K | -508.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.00M | -- | -- | -- | -- |
| Cash from Investing | -2.00M | -- | -- | -- | -- |
| Total Debt Issued | 73.20K | 125.00K | 0.00 | 0.00 | 1.30M |
| Total Debt Repaid | -198.20K | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 6.80M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.68M | 125.00K | 0.00 | 0.00 | 1.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.57M | -224.70K | -422.00K | -610.00K | 791.40K |